Envision Report

Published January 22, 2018

Europe RNAi Technology Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Download Free Sample Report!

RNAi technology is a process which inhibits gene expression by neutralising the targeted mRNA. In the fields of pharmaceutical and biotechnology, RNAi technology will help to improve technologies in therapeutics and drug discovery. RNAi is commonly known as co-suppression or quelling.

Europe RNAi Technology Market Segments Size & Growth:

Europe RNAi Technology Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by increasing research activities in RNAi technology mainly in cancer. However, reimbursement and FDA regulations hinder the growth of the Europe RNAi technology market.

Europe RNAi Technology Market Segments Share:

Europe RNAi Technology Market is categorised into by application which consists of agriculture, drug discovery, research & development, and therapeutics. Within the RNAi technology market, the therapeutic segment is further classified by oncology, heart ailment, neurodegenerative disease, respiratory disorders, autoimmune hepatitis, and metabolic disorders. Research and development have the most significant share due to increase in research developments in RNAi technology mainly on chronic diseases, such as cancer.

By Geography, Germany is dominating the Europe RNAi technology market, and the growth in Europe is mainly attributed because of considerable investments in R&D activities and advancements in therapies. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rapidly increasing pharmaceutical infrastructure and the government initiatives.

Europe RNAi Technology Market Segments Trends:

  • In recent research, Thermo Fisher Scientific Inc. has developed a new technology to reduce the gene function by mammalian gene expression.
  • In October 2017, emerging new RNAi technologies has laid a new-path in crop production.
  • In January 2017, Qiagen N.V. has acquired OmicSoft Corporation to access multi-omics data management solutions.

Europe RNAi Technology Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

  • Ionis Pharmaceuticals Inc.
  • Benitec Biopharma Ltd
  • Silence Therapeutics
  • Takara Bio Inc.
  • Quark Pharmaceuticals Inc.

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2Porter’s Five Force Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1. Drivers

4.1.1 Increasing research activities in RNAi technology mainly in cancer

4.2. Restraints

4.2.1 FDA regulations and reimbursement facilities

4.3 Opportunities

4.3.1 Rising demand for genetics-based on In-Vitro-Diagnostics

4.4 Challenges

4.4.1 Determining design for siRNA sequence and off-target effects.

Chapter 5 Europe RNAi Technology Market – By Application

5.1 Agriculture

5.2 Research and development

5.3 Drug discovery

5.4 Therapeutics

5.4.1 Autoimmune Hepatitis

5.4.2 Ocular Disorders

5.4.3 Hepatitis B and C

5.4.4 Oncology

5.4.5 Respiratory Disorders

5.4.6 Heart ailments

5.4.7 Neurodegenerative disease

5.4.8 Others 

Chapter 6 Europe RNAi Technology Market – By Geography

6.1 Introduction

6.2 Europe

6.2.1.  U.K.

6.2.2.  Germany

6.2.3.  France

6.2.4. Italy

6.2.5.  Spain

6.2.6. Rest of Europe

Chapter 7 Europe RNAi Technology Market – Company Profiles

7.1. Ionis Pharmaceuticals Inc.

7.2. Benitec Biopharma Ltd

7.3. Silence Therapeutics

7.4. Takara Bio Inc. (Clonetch)

7.5. Quark Pharmaceuticals Inc.

7.6. Thermo Fisher Scientific Inc.

7.7. F. Hoffmann-La Roche Ag (Roche)

7.8. Alnylam Pharmaceuticals

7.9. Pfizer Inc.

7.10. Invitrogen.

7.11 Merck & Co. Inc. (Sigma Aldrich)

7.12 Qiagen NV

7.13 Arcturus Therapeutics

Chapter 8 Europe RNAi Technology Market – Competitive Landscape

8.1 Market Share Analysis

8.2 Strategies Adopted by top companies

8.3 Mergers, Acquisitions, Collaborations & Agreements

Chapter 9 Market Insights

9.1. Industry Experts Insights

9.2. Analysts Opinions

9.3. Investment Opportunities

Chapter 10 Appendix

10.1 List of Tables

10.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

 

©2018 - Envision Inteligence | All Rights Reserved.